📊 Nueva publicación sobre la evolución de la EII en los 5 primeros años tras el diagnóstico
Estudio prospectivo con más de 3.300 pacientes del registro EpidemIBD, liderado por Ana Garre, Javier P. Gisbert y @maria_chs y publicado en Alimentary Pharmacology & Therapeutics (@APandT) 👇
pubmed.ncbi.nlm.nih.gov/4286…
Javier P. Gisbert retweeted
Un artículo clave en el estudio de la historia natural de las #EII en el siglo XXI. Referencia obligada. Gracias a un equipazo coordinado y liderado por @maria_chs @jp_gisbert @EIILaPrincesa @geteccu #ECCO
📊 Nueva publicación sobre la evolución de la EII en los 5 primeros años tras el diagnóstico
Estudio prospectivo con más de 3.300 pacientes del registro EpidemIBD, liderado por Ana Garre, Javier P. Gisbert y @maria_chs y publicado en Alimentary Pharmacology & Therapeutics (@APandT) 👇
pubmed.ncbi.nlm.nih.gov/4286…
Javier P. Gisbert retweeted
En esta foto falta uno de los investigadores mundiales más importantes en la infección del Helicobacter Pylori.
Dr. Javier Pérez Gisbert
Creador e impulsor de la Red mundial Hp-EuReg – at Astigarraga, España
Javier P. Gisbert retweeted
New in @NEJM‼️
A comprehensive review on Helicobacter pylori infection — covering 40 years of progress, global burden, gastric cancer prevention, and the rising challenge of antibiotic resistance. 🦠📉
Read the full update here: nejm.org/doi/full/10.1056/NE… 📖✨
Javier P. Gisbert retweeted
🎉 Big congratulations to @miganuza, regional coordinator for Catalonia, for winning the Best Oral Presentation Award at #UEGWeek 2026! 🏆👏
He delivered a fantastic talk on the evolution of first-line empirical treatments in Europe during the "H. pylori: At the nexus of molecular mechanisms and clinical care" session. 🧬💊
Outstanding contribution to clinical care and research! 🚀✨
#UEGWeek2026 #Gastroenterology #Hpylori
Javier P. Gisbert retweeted
🙌 Huge thanks to the amazing researchers from Hp-EuReg and WorldHpReg for presenting their moderated posters at #UEGWeek 2026! 👏🧬
🎉 Special congratulations to @DiegoCasas8 & @MoreiraR_Leti for winning the Best Communication Award! 🏆✨
Outstanding work advancing science! 🚀
#UEGWeek2026 #Gastroenterology #Hpylori
Javier P. Gisbert retweeted
PREVALENCE, CLINICAL CHARACTERISATION AND THERAPEUTIC OUTCOMES OF NON-FISTULISING PERIANAL LESIONS IN CROHN’S DISEASE (ULCERS-CD): RESULTS FROM THE ENEIDA REGISTRY OF GETECCU - Our college @rosariosallu collaborate with @jp_gisbert @maria_chs @HUnivTO @my_ueg #UEGWeek @geteccu
Javier P. Gisbert retweeted
Key insights from our oral presentation at #UEGWeek2026 on H. pylori eradication therapy safety (presented by Pablo Parra)🎤📊:
🔹 Adverse events were frequent, but mostly mild-to-moderate🩹
🔹 Serious AEs were exceptional🛡️
🔹 Tolerability varied by regimen, but overall compliance stayed high💊✅
🔹 Patient & treatment factors drive AE risks👤🔬
#Hpylori #Gastroenterology #UEGWeek
Javier P. Gisbert retweeted
23 studies will be presented at #UEGWeek 2026! 🚀
🎤 2 Oral Presentations (by Pablo Parra and Mikel Ganuza)
💬 9 Moderated Posters
💻 12 Electronic Posters
📊 Total breakdown: 18 from #HpEuReg + 5 from #WorldHpReg
A huge thank you to all investigators for their outstanding contribution! 👏
🇪🇸 Barcelona | 17–20 October
#Gastroenterology #Research #Hpylori
Javier P. Gisbert retweeted
Read open access via bit.ly/4jNVap6 "Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease"
#GItwitter #IBD #surgery
Javier P. Gisbert retweeted
Great effort from @geteccu under the extraordinary leadership of @jp_gisbert @maria_chs @EIILaPrincesa finally available in @APandT open-access @aegastro @sepdigestiva
Javier P. Gisbert retweeted
Y muchísimas gracias a @EIILaPrincesa el equipo soñado, hacedores de sueños
Javier P. Gisbert retweeted
🎉 Thrilled to announce that our new #HpEuReg paper, "Lack of usefulness of literature-based Helicobacter pylori resistance data for predicting first-line empirical treatment effectiveness", has been ACCEPTED in Helicobacter (Q1)! 📖 In press!
Big thanks to all co-authors for their brilliant work! 👏
#Helicobacterpylori #Hpylori #Gastroenterology #Research
Javier P. Gisbert retweeted
¡Ya se ha publicado el VI Consenso Español sobre el Manejo de la Infección por H. pylori en la revista Gastroenterología y Hepatología! 📄🦠
Podéis descargarlo de forma gratuita hasta el 19 de noviembre a través de este enlace: 🔗 authors.elsevier.com/a/1nsfZ…
Esperamos que sea de vuestro interés y resulte útil en la práctica clínica diaria. 🩺
Javier P. Gisbert retweeted
Behind every large international registry there are people who make collaboration possible.
As we celebrate 100,000 patients included in the Hp-EuReg, we would like to recognise and thank our National Coordinators for their essential role in connecting centres, supporting investigators, and strengthening this international network.
This milestone is the result of a truly collective effort.
Thank you for being part of the Hp-EuReg journey.
#HpEuReg #Helicobacterpylori #Hpylori #ResearchCollaboration #Gastroenterology #RealWorldEvidence
Javier P. Gisbert retweeted
What does the collaboration behind 100,000 Hp-EuReg patients look like?
🌍 Explore our interactive map and discover the contribution of each participating country, including:
• Patients included
• Participating centres
• National Coordinator
👉 100k-patients-hpeureg.netlif…
A truly international collaborative effort built over more than a decade.
#HpEuReg #Hpylori #Helicobacterpylori #RealWorldEvidence #InternationalCollaboration #Gastroenterology
Javier P. Gisbert retweeted
The Hp-EuReg has reached a major milestone: 100,000 patients included.
More than a decade of collaboration, real-world data, and shared commitment to improving the management of Helicobacter pylori infection.
This achievement has only been possible thanks to the contribution of all participating investigators, centres, National Coordinators and, above all, our patients.
🎥 We are proud to share this short video celebrating the journey so far.
100,000 patients — and the journey continues.
#HpEuReg #Helicobacterpylori #Hpylori #RealWorldEvidence #Gastroenterology #Research
Javier P. Gisbert retweeted
Great session at #EHMSG2026! 🎤
Our Data Manager, Pablo Parra, presenting the latest findings on rifabutin-based therapy from the #HpEuReg. Excellent discussion on clinical outcomes and real-world experience! 💊📊
📸 Highlights from the talk 👇
#Helicobacter #Hpylori #Gastroenterology #Research #EHMSG
Javier P. Gisbert retweeted
Great energy at #EHMSG2026 in Belgrade! 🇷🇸
Our team is presenting 22 posters with the latest insights from #HpEuReg and #WorldHpReg. Stop by to chat with us, dive into the data, and say hi! 👋📊
📸 Spot us in the poster hall 👇
#Helicobacter #Hpylori #Gastroenterology #Research #EHMSG
Javier P. Gisbert retweeted
23 studies will be presented at #EHMSG2026: 1 oral communication by our Scientific Director, Dr. Olga P. Nyssen, 15 #HpEuReg posters and 7 from the #WorldHpReg network.
Thank you to all investigators for their outstanding contribution!
🇷🇸 Belgrade | 10–12 September
Full programme below 👇


























